Brief: Jilin Province Huinan Changlong Bio-Pharmacy Co says qtrly turnover RMB156.4 mln
Aug 14 (Reuters) - Jilin Province Huinan Changlong
Bio-pharmacy Co Ltd 8049.HK :
* Qtrly turnover rmb156.4 million versus rmb147.4 million
* Board does not recommend payment of an interim dividend
for six months ended
* Qtrly profit attributable to equity holders of company
rmb37.5 million versus rmb36 million
Source text for Eikon: urn:newsml:reuters.com:*:nHKS81XDJ4
Further company coverage: 8049.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Jilin Province Huinan Changlong Bio-pharmacy Co
See all newsBrief: Jilin Province Huinan Changlong Bio-Pharmacy Profit For Year Attributable Rmb198.9 Million
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Structured Deposit Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product For RMB50 MLN
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Management Product
Brief: Jilin Province Huinan Changlong Bio-Pharmacy Subscribes To ICBC Wealth Product For RMB50 MLN